Evommune Inc EVMN Q1 2026 Earnings EPS Beats Estimates as PreRevenue Biotech Focuses on Pipeline Progress DBRG Q1 2026 Earnings EPS Misses Estimates Amid Mixed Market Response ZIM Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions CIMP Q1 2026 Earnings EPS Beats Estimates as Mortgage REIT Maintains Stable Performance SIM Q1 2023 Earnings EPS Falls Short of Estimates Missing by Over 57 COYA Q1 2026 Earnings NarrowerthanExpected Loss as Biotech Advances Pipeline